SATURDAY, APRIL 21, 2018
The World Health Organization's Expanded Programme on Immunization (EPI) recently observed its 40th anniversary. Read More »
The Centers for Disease Control and Prevention's Advisory Committee on Immunization practices recently recommended AstraZeneca's Live Attenuated Influenza Vaccine (LAIV) for healthy children between 2-8 years of age. Read More »
Health officials across the world recently called on lawmakers to do more to address the growing threat of antimicrobial resistance (AMR), which may hamper the prevention and treatment of infectious diseases. Read More »
Specialty vaccine developer PaxVac, Inc., announced positive efficacy results on Tuesday from a 90-day study of its single-dose cholera vaccine candidate. Read More »
The National Institutes of Health (NIH) recently issued more than $42 million grants to six medical clinical sites nationwide to choose undiagnosed diseases and develop approaches to test for the conditions. Read More »
A recent study examining exemptions from vaccination laws in schools found higher rates of exemption in private versus public institutions. Read More »
A recent study conducted by the Agency for Healthcare Research & Quality (AHRQ) found that serious adverse events resulting from widely used vaccines in the U.S. are rare. Read More »
The European Centre for Disease Prevention and Control (ECDC) released a report on Wednesday detailing the spread of the Middle East respiratory syndrome coronavirus (MERS-CoV) since April 2012. Read More »
Novartis announced on Wednesday that it began shipment in the U.S. market of its influenza vaccines for the 2014-2015 season. Read More »
Alerts Sign-up
